Indication
Klebsiella pneumoniae infection
1 clinical trial
2 products
Product
Kleb4VClinical trial
Safety and Immunogenicity of a Klebsiella Pneumoniae Tetravalent Bioconjugate Vaccine (Kleb4V) Administered to Healthy Adults: A FTIH Phase I/II Randomized and Controlled StudyStatus: Completed, Estimated PCD: 2022-09-26
Product
Placebo